Not Yet RecruitingNot Applicable

Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Cerebral Palsy

Turkey (Türkiye)30 participantsStarted 2026-05-01

Plain-language summary

This randomized, controlled, single-blind trial aims to investigate the effectiveness of neuromuscular electrical stimulation (NMES) combined with oral motor therapy in reducing drooling severity among children with cerebral palsy. Participants will be allocated to an intervention group (oral motor therapy plus NMES), a control group (oral motor therapy alone) and a sham group (oral motor therapy with placebo NMES).

Who can participate

Age range4 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of cerebral palsy (unilateral/bilateral spastic, ataxic, dyskinetic, or mixed type) * Presence of drooling control problems * Age between 4 and 17 years * Gross Motor Function Classification System (GMFCS) levels 2, 3, 4, or 5 * Stable drooling severity for at least one month prior to enrollment * Drooling Severity and Frequency Scale (DSFS) score of 3 or higher Exclusion Criteria: * Diagnosis of dysphagia * Use of medications affecting drooling within the past 72 hours * Upper respiratory tract infection and/or salivary gland infection during the study period * History of botulinum toxin injection to the salivary glands

What they're measuring

Change in Drooling Severity and Frequency Scale (DSFS) Score

Timeframe: At Baseline and at 4th Week (after completion of 12 therapy sessions)

Change in Drooling Impact Scale (DIS) Score

Timeframe: At Baseline and at 4th Week (after completion of 12 therapy sessions)

Trial details

NCT IDNCT07069257

SponsorAslinur Keles Ercisli, MD, PhD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

ZEHRA AYCAN

+90 553 450 00 22 zehrabir.123@gmail.com